[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:single-ventricle-heart-disease":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":41,"states":42},"Single Ventricle Heart Disease",5,[7,14,21,28,35],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT06918795","Fontan Fitness Trial",[],"RECRUITING","2026-08-26T02:15:48.613507Z","2026-05-05T02:43:28.016697Z",{"nct_id":15,"title":16,"phases":17,"status":11,"updated_at":19,"content_modified":20},"NCT05918211","Fontan Udenafil Exercise Longitudinal Assessment Trial - 2",[18],"Phase 3","2026-08-26T02:18:14.396999Z","2026-05-05T02:43:26.928143Z",{"nct_id":22,"title":23,"phases":24,"status":11,"updated_at":26,"content_modified":27},"NCT06613477","PK\u002FPD of Digoxin in Infants With SVHD",[25],"Phase 1\u002FPhase 2","2026-08-03T03:39:57.435220Z","2026-05-05T02:35:31.753563Z",{"nct_id":29,"title":30,"phases":31,"status":11,"updated_at":33,"content_modified":34},"NCT06762964","CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation",[32],"Phase 2","2026-08-26T02:17:05.172421Z","2026-05-05T02:43:28.475327Z",{"nct_id":36,"title":37,"phases":38,"status":11,"updated_at":39,"content_modified":40},"NCT07686341","PRecision Integrated Saturation Monitor",[],"2026-08-26T02:16:08.402952Z","2026-07-19T19:36:05.150408Z",[],[]]